Docket Number:11A-880510AB
Inventor: Chen Shui-Tein, Huang Chun-Ming, Jiaang Weir-Tom, Tseng Ping-Hui
IP Status: US 6383812B1, TW I240002
Abstract:
Liver cancer treatment, liver regeneration, and cholesterol lowering are clinical big issues to cure liver disease. However, in short of liver tissue specific drugs, complicated drug synthesis, uncompleted biological and clinical tests result in many difficulties in liver disease treatment. We have successfully developed a more simple and effective synthetic method to synthesize R-YEEE. From confocal microscopic observation, we have found that fluorescein-labeled R-YEEE can bind and internalize into various human heptoma cell via ASGPr-mediated endocytosis. R-YEEE can transport effectively antisense oligonucleotide to protein kinase C-α (PKC-α), BLOCK PKC-α expression, and then cause apoptosis of human heptoma cells.
Fields of Application:
- As a liver-drug carrier
- As a liver tissue marker
- Application for gene therapy of liver disease
- Application for drug development of anti-liver disease
Advantages when compared to the existing technologies:
- More simple and effective synthetic method to synthesize R-YEEE.
- High liver cell and tissue specifity of R-YEEE delivery.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
